Container
Latest SmithKline Beecham Corp. Patents:
- 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3?-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
- Thrombopoietin activity modulating compounds and methods
- Thrombopoietin mimetics
- CCR5 antagonists as therapeutic agents
- Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors
The dot-dash broken lines in
Claims
The ornamental design for a container, as shown and described.
D231087 | April 1974 | Edwards |
D381906 | August 5, 1997 | Bartsch |
D390466 | February 10, 1998 | Mao |
D456265 | April 30, 2002 | Spear |
D475923 | June 17, 2003 | Renz |
D529380 | October 3, 2006 | Yelland |
D535563 | January 23, 2007 | Martin |
D552993 | October 16, 2007 | Rathbone et al. |
D569253 | May 20, 2008 | Cracchiolo |
D588936 | March 24, 2009 | Ioannides et al. |
D593414 | June 2, 2009 | Hunter |
D596032 | July 14, 2009 | Shin et al. |
D596035 | July 14, 2009 | Shin et al. |
Type: Grant
Filed: Sep 9, 2008
Date of Patent: Feb 2, 2010
Assignee: SmithKline Beecham Corp. (Philadelphia, PA)
Inventors: William J. Kooser (Pittsburgh, PA), Mark R. Prus (Pittsburgh, PA)
Primary Examiner: Ian Simmons
Assistant Examiner: Dana L Sipos
Attorney: Dara L. Dinner
Application Number: 29/324,229